Qiagen N.V. (QGEN)
NYSE: QGEN · Biological Products, (No Diagnostic Substances) · filing with the SEC since 1998
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026142 patents granted to the 20 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Qiagen N.V.’s names, not what it holds today.
Patents granted
142
139 utility, 3 design, 1976 to Dec 31, 2025
Granted in 2025
6
Against 5 in 2024 and 4 in 2023
Applications published
141
8 of them in 2025
Names they are printed under
20
a subsidiary, its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology15
Measurement9
Analysis of biological materials4
Computer technology3
Organic fine chemistry1
Chemical engineering1
Machine tools1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name20 counted
QIAGEN GAITHERSBURG INC. a subsidiary
US, as the owner printed on each patent
37 published
QIAGEN Sciences, LLC a subsidiary
US, as the owner printed on each patent. 4 more under the same name are not counted (printed in DE, printed in NL)
5 published
QIAGEN SCIENCES, LLC a subsidiary
named as the applicant on its applications, in US. 2 more under the same name are not counted (printed in NL)
62 published
QIAGEN North American Holdings, Inc a subsidiary
US, as the owner printed on each patent
4 published
QIAGEN MANCHESTER LIMITED a subsidiary
GB, as the owner printed on each patent
4 published
QIAGEN Redwood City, Inc. a subsidiary
US, as the owner printed on each patent
5 published
QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS GMBH a subsidiary
DE, as the owner printed on each patent
0 published
QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS LIMITED a subsidiary
named as the applicant on its applications, in GB
6 published
QIAGEN Hamburg GmbH a subsidiary
DE, as the owner printed on each patent
3 published
QIAGEN BEVERLY LLC a subsidiary
named as the applicant on its applications, in US
4 published
QIAGEN GAITHERSBURG, INC. a subsidiary
named as the applicant on its applications, in US
3 published
GNX DATA SYSTEMS LTD. a subsidiary
IL, as the owner printed on each patent
0 published
QIAGEN MANCHESTER LIMITED a subsidiary
named as the applicant on its applications, in GB
2 published
Qiagen Beverly, LLC a subsidiary
US, as the owner printed on each patent
0 published
Qiagen N.V. its own name
NL, as the owner printed on each patent
0 published
Verogen, Inc. a subsidiary
US, as the owner printed on each patent
2 published
GNX DATA SYSTEMS LTD. a subsidiary
named as the applicant on its applications, in IL
1 published
QIAGEN Hamburg GmbH a subsidiary
named as the applicant on its applications, in DE
1 published
QIAGEN NORTH AMERICAN HOLDINGS, INC. a subsidiary
named as the applicant on its applications, in US
1 published
QIAGEN Redwood City, Inc. a subsidiary
named as the applicant on its applications, in US
1 published
Names not counted (3)
QIAGEN N.V.
Most of its patents print DE; this name counts in NL. 267 granted and 179 published under it are not counted.
QIAGEN N.V.
Most of its patents print DE; this name counts in NL. 0 granted and 165 published under it are not counted.
QIAGEN N.V.
Most of its patents print NO; this name counts in NL. 0 granted and 3 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
Newest applications publishedan application is a clue, never a plan
What it applied for, 2024 to 2025: Biotechnology 9 · Analysis of biological materials 3 · Measurement 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.